Literature DB >> 19540809

CD28(-) T cells: their role in the age-associated decline of immune function.

Nan-Ping Weng1, Arne N Akbar, Jorg Goronzy.   

Abstract

The accumulation of CD28(-) T cells, particularly within the CD8 subset, is one of the most prominent changes during T-cell homeostasis and function associated with aging in humans. CD28, a major co-stimulatory receptor, is responsible for the optimal antigen-mediated T-cell activation, proliferation and survival of T cells. CD28(-) T cells exhibit reduced antigen receptor diversity, defective antigen-induced proliferation and a shorter replicative lifespan while showing enhanced cytotoxicity and regulatory functions. Gene expression analyses reveal profound changes of CD28(-) T cells in comparison to their CD28(+) counterparts and corroborate their functional differences. Here we review recent advances in our understanding of CD28(-) T cells and their role in the age-associated decline of immune function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540809      PMCID: PMC2801888          DOI: 10.1016/j.it.2009.03.013

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  86 in total

1.  Mechanism for down-regulation of CD28 by Nef.

Authors:  T Swigut; N Shohdy; J Skowronski
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Functional disruption of the CD28 gene transcriptional initiator in senescent T cells.

Authors:  A N Vallejo; C M Weyand; J J Goronzy
Journal:  J Biol Chem       Date:  2000-11-07       Impact factor: 5.157

3.  Down-regulation of CD28 expression by TNF-alpha.

Authors:  E Bryl; A N Vallejo; C M Weyand; J J Goronzy
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

4.  The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells.

Authors:  D E Speiser; M Colonna; M Ayyoub; M Cella; M J Pittet; P Batard; D Valmori; P Guillaume; D Liénard; J C Cerottini; P Romero
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

5.  T-cell-mediated lysis of endothelial cells in acute coronary syndromes.

Authors:  Takako Nakajima; Stephanie Schulte; Kenneth J Warrington; Stephen L Kopecky; Robert L Frye; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circulation       Date:  2002-02-05       Impact factor: 29.690

6.  Perturbation of the T-cell repertoire in patients with unstable angina.

Authors:  G Liuzzo; S L Kopecky; R L Frye; W M O'Fallon; A Maseri; J J Goronzy; C M Weyand
Journal:  Circulation       Date:  1999-11-23       Impact factor: 29.690

7.  Loss of CD28 expression on CD8(+) T cells is induced by IL-2 receptor gamma chain signalling cytokines and type I IFN, and increases susceptibility to activation-induced apoptosis.

Authors:  N J Borthwick; M Lowdell; M Salmon; A N Akbar
Journal:  Int Immunol       Date:  2000-07       Impact factor: 4.823

8.  Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment.

Authors:  D M Sze; G Giesajtis; R D Brown; M Raitakari; J Gibson; J Ho; A G Baxter; B Fazekas de St Groth; A Basten; D E Joshua
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

9.  CD4+CD28- costimulation-independent T cells in multiple sclerosis.

Authors:  S Markovic-Plese; I Cortese; K P Wandinger; H F McFarland; R Martin
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

10.  Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis.

Authors:  J H Yen; B E Moore; T Nakajima; D Scholl; D J Schaid; C M Weyand; J J Goronzy
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

View more
  244 in total

1.  Gender specificity of altered human immune cytokine profiles in aging.

Authors:  Edward J Goetzl; Mei-Chuan Huang; Junko Kon; Kalpesh Patel; Janice B Schwartz; Katharine Fast; Luigi Ferrucci; Karen Madara; Dennis D Taub; Dan L Longo
Journal:  FASEB J       Date:  2010-05-07       Impact factor: 5.191

2.  Increased vitamin D is associated with decline of naïve, but accumulation of effector, CD8 T cells during early aging.

Authors:  Yong Gil Hwang; Hui-Chen Hsu; Fei-Chu Lim; Qi Wu; PingAr Yang; Gordon Fisher; Gary R Hunter; John D Mountz
Journal:  Adv Aging Res       Date:  2013-05

Review 3.  Dendritic cells and aging: consequences for autoimmunity.

Authors:  Anshu Agrawal; Aishwarya Sridharan; Sangeetha Prakash; Harsh Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2012-01       Impact factor: 4.473

4.  Primary biliary cirrhosis: bad genes, bad luck.

Authors:  Pietro Invernizzi; M Eric Gershwin
Journal:  Dig Dis Sci       Date:  2012-03       Impact factor: 3.199

5.  The role of nutrition in enhancing immunity in aging.

Authors:  Munkyong Pae; Simin Nikbin Meydani; Dayong Wu
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

6.  Tracing thymic output in older individuals.

Authors:  W A Mitchell; P O Lang; R Aspinall
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 7.  Treatment of Glioblastoma in the Elderly.

Authors:  Rebecca A Harrison; John F de Groot
Journal:  Drugs Aging       Date:  2018-08       Impact factor: 3.923

8.  Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice.

Authors:  Sujin Lee; Robert S Mittler; Martin L Moore
Journal:  J Immunol       Date:  2013-11-27       Impact factor: 5.422

9.  T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors.

Authors:  Jiemiao Hu; Chuang Sun; Chantale Bernatchez; Xueqing Xia; Patrick Hwu; Gianpietro Dotti; Shulin Li
Journal:  Clin Cancer Res       Date:  2018-02-01       Impact factor: 12.531

10.  CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis.

Authors:  Ratanesh Kumar Seth; Suvarthi Das; Ashutosh Kumar; Anindya Chanda; Maria B Kadiiska; Gregory Michelotti; Jose Manautou; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-07       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.